-
Something wrong with this record ?
Utility of global longitudinal strain in early identification of chronic cardiotoxicity in asymptomatic long-term malignant lymphoma survivors with normal left ventricle ejection fraction
E. Rihackova, M. Rihacek, L. Boucek, M. Vyskocilova, L. Elbl
Language English Country England, Great Britain
Document type Journal Article
Grant support
65269705
Ministry of Health, Czech Republic
65269705
Ministry of Health, Czech Republic
65269705
Ministry of Health, Czech Republic
65269705
Ministry of Health, Czech Republic
65269705
Ministry of Health, Czech Republic
NU21-09-00558
Agentura Pro Zdravotnický Výzkum České Republiky
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Nature Open Access
from 2011-12-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-12-01
- MeSH
- Anthracyclines adverse effects MeSH
- Adult MeSH
- Echocardiography * MeSH
- Ventricular Function, Left drug effects MeSH
- Global Longitudinal Strain MeSH
- Cardiotoxicity * etiology diagnosis MeSH
- Middle Aged MeSH
- Humans MeSH
- Lymphoma * drug therapy MeSH
- Adolescent MeSH
- Young Adult MeSH
- Follow-Up Studies MeSH
- Cancer Survivors * MeSH
- Retrospective Studies MeSH
- Stroke Volume drug effects MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Malignant lymphoma survivors are at increased risk for anthracycline and/or radiotherapy-induced chronic cardiotoxicity. Proper long-term follow-up is essential for malignant lymphoma survivors after-care. This study aimed to assess TTE parameters of potential subclinical cardiotoxicity and to examine their utility in diagnosing chronic cardiotoxicity. Improvement of the diagnostic process may precede the manifestation of cardiac adverse events. Main objective of the study was to improve the identification of cancer survivors in increased risk of treatment cardiotoxicity. To achieve this goal, utility of various echocardiography parameters was examined.In this retrospective study we analysed TTE of 167 subjects with speckle tracking according to the European Society of Echocardiography guidelines during the follow-up period. 88 of them were long-term lymphoma survivors diagnosed with malignant lymphoma between the years 1994-2015. Minimum follow up period was 5 years with the median of 10 years after anti-cancer treatment cessation. TTE were performed between the years 2017-2022 at cardio-oncology outpatient office during regular follow-up period. A total of 79 volunteers with no history of chronic heart failure (CHF) or decline in LVEF, 51 (64.6%) of whom were males, with the median age of 46 (16-58) years were included in the analysis as control group. Control subjects had various indications for TTE (e.g. preoperative examination, benign palpitations, or with well controlled arterial hypertension taking two antihypertensives at most). Ischemic heart disease was ruled out by stress test. None of the control subjects had history of stroke or chronic lower limb ischemia. All control subjects were considered clinically stable with no sign of cardiac impairment caused by primary disease. Both cancer survivors and control group were divided into subgroups based on LVEF: lower normal LVEF (53-61%), and higher normal LVEF (> 61%). Survivors with lower normal LVEF (53-61%) had a statistically significant decline in GLS compared to those with higher normal LVEF (> 61%). This phenomenon was not observed in control group indicating a possible additional diagnostic value of this parameter. Inclusion of GLS assessment in follow-up TTE examination of subjects with lower normal LVEF may improve the sensitivity of detection of chronic cardiotoxicity. Patients with declined GLS and lower normal LVEF are candidates for intensified follow-up to precede manifestation of cardiac adverse events.
Department of Hematology and Transfusion AGEL Hospital Prostejov Prostejov 796 01 Czech Republic
Department of Laboratory Methods Faculty of Medicine Masaryk University Brno Czech Republic
Department of Pharmacology Faculty of Medicine Masaryk University Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009473
- 003
- CZ-PrNML
- 005
- 20250429135303.0
- 007
- ta
- 008
- 250415s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-025-93933-2 $2 doi
- 035 __
- $a (PubMed)40102510
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Rihackova, Eva $u Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 245 10
- $a Utility of global longitudinal strain in early identification of chronic cardiotoxicity in asymptomatic long-term malignant lymphoma survivors with normal left ventricle ejection fraction / $c E. Rihackova, M. Rihacek, L. Boucek, M. Vyskocilova, L. Elbl
- 520 9_
- $a Malignant lymphoma survivors are at increased risk for anthracycline and/or radiotherapy-induced chronic cardiotoxicity. Proper long-term follow-up is essential for malignant lymphoma survivors after-care. This study aimed to assess TTE parameters of potential subclinical cardiotoxicity and to examine their utility in diagnosing chronic cardiotoxicity. Improvement of the diagnostic process may precede the manifestation of cardiac adverse events. Main objective of the study was to improve the identification of cancer survivors in increased risk of treatment cardiotoxicity. To achieve this goal, utility of various echocardiography parameters was examined.In this retrospective study we analysed TTE of 167 subjects with speckle tracking according to the European Society of Echocardiography guidelines during the follow-up period. 88 of them were long-term lymphoma survivors diagnosed with malignant lymphoma between the years 1994-2015. Minimum follow up period was 5 years with the median of 10 years after anti-cancer treatment cessation. TTE were performed between the years 2017-2022 at cardio-oncology outpatient office during regular follow-up period. A total of 79 volunteers with no history of chronic heart failure (CHF) or decline in LVEF, 51 (64.6%) of whom were males, with the median age of 46 (16-58) years were included in the analysis as control group. Control subjects had various indications for TTE (e.g. preoperative examination, benign palpitations, or with well controlled arterial hypertension taking two antihypertensives at most). Ischemic heart disease was ruled out by stress test. None of the control subjects had history of stroke or chronic lower limb ischemia. All control subjects were considered clinically stable with no sign of cardiac impairment caused by primary disease. Both cancer survivors and control group were divided into subgroups based on LVEF: lower normal LVEF (53-61%), and higher normal LVEF (> 61%). Survivors with lower normal LVEF (53-61%) had a statistically significant decline in GLS compared to those with higher normal LVEF (> 61%). This phenomenon was not observed in control group indicating a possible additional diagnostic value of this parameter. Inclusion of GLS assessment in follow-up TTE examination of subjects with lower normal LVEF may improve the sensitivity of detection of chronic cardiotoxicity. Patients with declined GLS and lower normal LVEF are candidates for intensified follow-up to precede manifestation of cardiac adverse events.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a přežívající onkologičtí pacienti $7 D000073116
- 650 12
- $a lymfom $x farmakoterapie $7 D008223
- 650 12
- $a echokardiografie $7 D004452
- 650 12
- $a kardiotoxicita $x etiologie $x diagnóza $7 D066126
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a tepový objem $x účinky léků $7 D013318
- 650 _2
- $a funkce levé komory srdeční $x účinky léků $7 D016277
- 650 _2
- $a mladý dospělý $7 D055815
- 650 _2
- $a antracykliny $x škodlivé účinky $7 D018943
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a globální longitudinální strain $7 D000094582
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Rihacek, Michal $u Department of Laboratory Methods, Faculty of Medicine, Masaryk University, Brno, Czech Republic. m.rihacek@me.com $u Department of Hematology and Transfusion, AGEL Hospital Prostejov, Prostejov, 796 01, Czech Republic. m.rihacek@me.com
- 700 1_
- $a Boucek, Lubos $u Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Vyskocilova, Maria $u Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Elbl, Lubomir $u Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 15, č. 1 (2025), s. 9372
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40102510 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135259 $b ABA008
- 999 __
- $a ok $b bmc $g 2311076 $s 1246554
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 15 $c 1 $d 9372 $e 20250318 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- GRA __
- $a 65269705 $p Ministry of Health, Czech Republic
- GRA __
- $a 65269705 $p Ministry of Health, Czech Republic
- GRA __
- $a 65269705 $p Ministry of Health, Czech Republic
- GRA __
- $a 65269705 $p Ministry of Health, Czech Republic
- GRA __
- $a 65269705 $p Ministry of Health, Czech Republic
- GRA __
- $a NU21-09-00558 $p Agentura Pro Zdravotnický Výzkum České Republiky
- LZP __
- $a Pubmed-20250415